Elevations of Cardiac Troponin‐I Quantified with the Erenna® cTnI Immunoassay are an Early Indicator of Heart Muscle Injury in Studies of Cardiotoxicity

This application note describes the utility of the Erenna Immunoassay System and the Erenna cTnI Assay towards early assessment of cardiotoxicity in rats. Due to its unique high definition technology it is shown that elevated levels of cTnI in serum can be detected earlier with the Erenna Immunoassay System.